Federal Register Notice: FDA is establishing a public docket for comments on agency activities performed under the FDA Safety and Innovation Act, Patient Participation in Medical Product Discussions. The agency intends to gather input from stakeholders on strategies to obtain the views of patients during the medical product development process and ways to consider patients’ perspectives during regulatory discussions. To view this notice, click here.
